Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.

Daly PA, Krieger DR, Dulloo AG, Young JB, Landsberg L.

Int J Obes Relat Metab Disord. 1993 Feb;17 Suppl 1:S73-8.

PMID:
8384187
2.
3.

Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.

Toubro S, Astrup AV, Breum L, Quaade F.

Int J Obes Relat Metab Disord. 1993 Feb;17 Suppl 1:S69-72.

PMID:
8384186
4.

Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.

Molnár D, Török K, Erhardt E, Jeges S.

Int J Obes Relat Metab Disord. 2000 Dec;24(12):1573-8.

PMID:
11126208
5.

The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.

Toubro S, Astrup A, Breum L, Quaade F.

Int J Obes Relat Metab Disord. 1993 Dec;17 Suppl 3:S73-7; discussion S82.

PMID:
8124407
6.

Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.

Breum L, Pedersen JK, Ahlstrøm F, Frimodt-Møller J.

Int J Obes Relat Metab Disord. 1994 Feb;18(2):99-103.

PMID:
8148931
7.

Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.

Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T.

Int J Obes Relat Metab Disord. 2002 May;26(5):593-604.

PMID:
12032741
8.

Ephedrine, caffeine and aspirin promote weight loss in obese subjects.

Krieger DR, Daly PA, Dulloo AG, Ransil BJ, Young JB, Landsberg L.

Trans Assoc Am Physicians. 1990;103:307-12. No abstract available.

PMID:
2132541
9.
11.

Pharmacology of thermogenic drugs.

Astrup A, Toubro S, Christensen NJ, Quaade F.

Am J Clin Nutr. 1992 Jan;55(1 Suppl):246S-248S. Review.

PMID:
1345887
12.

Herbal simulation of ephedrine and caffeine in treatment of obesity.

Dulloo AG.

Int J Obes Relat Metab Disord. 2002 May;26(5):590-2. Review. No abstract available.

PMID:
12032740
13.

The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.

Buemann B, Marckmann P, Christensen NJ, Astrup A.

Int J Obes Relat Metab Disord. 1994 May;18(5):329-32.

PMID:
8061726
14.
15.
16.

The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss.

Liu AG, Smith SR, Fujioka K, Greenway FL.

Obesity (Silver Spring). 2013 Oct;21(10):1991-6. doi: 10.1002/oby.20416. Epub 2013 Jun 11.

17.

Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females.

Bracale R, Petroni ML, Davinelli S, Bracale U, Scapagnini G, Carruba MO, Nisoli E.

PLoS One. 2014 Jun 6;9(6):e98244. doi: 10.1371/journal.pone.0098244. eCollection 2014.

18.

Treatment of hypothalamic obesity with caffeine and ephedrine.

Greenway FL, Bray GA.

Endocr Pract. 2008 Sep;14(6):697-703.

PMID:
18996788
19.
20.

Pharmacological and clinical studies of ephedrine and other thermogenic agonists.

Astrup A, Breum L, Toubro S.

Obes Res. 1995 Nov;3 Suppl 4:537S-540S. Review.

Supplemental Content

Support Center